Research chemicals sit in the same underwriting territory as research peptides: restricted by mainstream aggregators, served by a smaller set of processors who price the category deliberately. If you sell in this space and want card payments, this is the layer you're buying from.
The mechanics are unglamorous and mostly within your control — which is good news, because it means approval is largely a preparation problem.
- Mainstream aggregators won't serve this category. Specialist acquirers will, at a price.
- Approval is mostly a documentation and website exercise. Underwriters read your site before your paperwork.
- Disclose accurately. Softening the category on the application is what turns a routine closure into a six-month fund hold.
- Expect a reserve. Negotiate the cap and release window, not its existence.
- Applications stall on missing documents far more than on the category.
Why the category is classified this way
"High-risk" is not a judgement about legitimacy. It describes exposure from the acquiring bank's perspective, and it's driven by measurable things:
- Chargeback propensity. Card-not-present, shipped goods, technical products — a combination that produces disputes.
- Regulatory variability. What's permitted differs by jurisdiction and can change, making forward risk hard to price.
- Cross-border shipping. More delivery failure modes, more disputes, more compliance surface.
- Reputational sensitivity for the sponsoring bank.
Aggregators are built around automated onboarding at enormous scale. That model can't accommodate categories requiring individual assessment, so they exclude them by policy. Specialist acquirers do the assessment manually and charge for it.
You are not sneaking into a restricted club. You're buying a service that costs more because someone is genuinely evaluating your business.
The disclosure rule
Everything else on this page is secondary to this.
This is also why founders who've been burned once are often easier to underwrite the second time: they arrive with full disclosure, documented history, and no incentive to obscure anything.
What underwriters review
Your website, first
Assume a person will open your site and read it critically before looking at a single document.
- Product and category pages. Accurate identification, clear research-use-only framing, no dosing or administration guidance, no human-use language, no therapeutic or benefit claims. This applies to old blog posts too.
- Policies that exist and are reachable. Refund, shipping, privacy, terms — linked from the footer and matching how you actually operate. A refund policy you don't honour is worse than not having one.
- Contact reality. Working phone number, genuine business address, support email on your own domain. A contact form plus a free-mail address reads as a red flag.
- A finished site. Not a placeholder, not lorem ipsum on the about page, not broken images. Underwriters read an unfinished site as an unfinished business.
Then your paperwork
| Document | What it establishes |
|---|---|
| Registered entity + EIN | A real business exists, and who is behind it |
| Business bank account in the entity's name | Where settlements land — personal accounts get declined |
| 3–6 months of bank statements | Genuine trading volume and cash flow |
| Prior processing statements | Real chargeback ratios rather than projections |
| Government ID, all 25%+ owners | Beneficial ownership requirements |
| Fulfilment description | Who ships, from where, how fast, what happens on failure |
| Chargeback history and prevention plan | The numbers, and what you do about them |
| Supplier documentation | Where product comes from and what accompanies it |
Pricing and reserves
Specific rates vary enough by volume, history and acquirer that any figure quoted online is close to meaningless. The reliable part is the shape:
- A meaningfully higher effective rate than aggregator headline pricing
- Possible application and setup fees — reputable processors explain these rather than burying them
- Monthly account and gateway fees
- Per-chargeback fees, which escalate quickly if your ratio drifts
- A reserve
On reserves: expect one. The useful negotiation isn't whether, it's the structure. Ask for a cap — uncapped rolling reserves scale painfully with growth. Push on the release window, since 90 days versus 180 is a large cash-flow difference at the same percentage. And get written conditions for review after a period of clean history.
Rolling reserves covers modelling the hold against your inventory cycle — the calculation founders skip and then get caught by in month four.
Preparing the application
Work through this before approaching anyone. Being organised measurably improves both your approval odds and your terms, because it signals an operator rather than a hobbyist.
- Registered entity, EIN, business bank account in the entity's name
- 3–6 months of business bank statements
- Prior processing statements, if any exist
- Government ID and ownership breakdown for every 25%+ owner
- A live, finished website with policies linked in the footer
- Compliance framing audited across every product, category and blog page
- Working phone, real business address, domain-based support email
- Written fulfilment description, including who ships and from where
- An honest, prepared answer on any prior termination or MATCH listing
- A documented chargeback-prevention plan
Chargeback prevention is the long game
Your dispute ratio determines whether your reserve gets reviewed downward, whether your rate improves, and ultimately whether the account survives. Build these in from day one:
- A recognisable billing descriptor — a large share of disputes are "I don't recognise this charge"
- Tracked shipping, always, with delivery confirmation retained
- Signature confirmation on high-value orders
- Fast, monitored support — many disputes happen simply because nobody replied
- Accurate product pages — disputes rise when what arrived isn't what was described
- A refund policy you actually follow — a refund costs one order; a chargeback costs the order, a fee, and a mark on the ratio
The alternative worth considering
Card processing isn't the only route. An inquiry-based ordering model removes the public checkout entirely — researchers request a quote, you review the account and invoice.
It adds friction and slows the funnel. In exchange there's no processor sitting on your storefront to freeze, and at higher order values many buyers in this space prefer invoicing anyway. Plenty of mature operations run hybrid: an underwritten account for standard orders, an inquiry path for large or unusual volume.
The takeaway
Getting a research chemical merchant account approved is mostly preparation, not persuasion. Assemble the documents, build a site that survives being read critically by a stranger, describe the business accurately, and negotiate the reserve terms that genuinely move.
The founders who struggle are almost always the ones who applied early with a half-finished site and a category description they hoped nobody would examine. That approach doesn't fail at the application stage. It fails six months later, with your balance inside it.